| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | -0.0096 | 0.8 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.8 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | 0.0081 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0094 | 0.8 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |